The nation of Zimbabwe has turned down a major American health deal worth 367 million US dollars (272 million pounds) spanning five years because of Washington's insistence on sensitive data.
This rejection came to light after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
An official representative has since explained that the US was requesting genetic material for scientific study and commercial purposes while was not willing to share the resulting advantages from any future vaccines.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had provided over $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more talks to reach a deal acceptable to all parties so the country's critical HIV treatment initiative can continue.
Wider Context
This rejection comes after a comparable situation in neighbouring Kenya, where a court blocked a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance openness and accountability.
Based on reports, Sixteen nations in Africa have so far signed similar agreements, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation might have yielded immense advantages for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might result from that provided information," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the final treatments would be accessible to our population should a new health crisis arise."
National Interest and Global Health
He also noted that the American exit from the global health body and its push of one-on-one health agreements were upending frameworks previously set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to develop them."
The government's concerns over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage further discussions with our American counterparts on how subsequent collaboration could be structured in a manner that respects the independence and interests of each country."
Health Experts Reaction
A leading public health body expressed it understood the official position, but recommended that talks should continue given that much of the nation's HIV programmes were funded by external financing.
"Where specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it said.
The halted deal emphasises the ongoing challenges between receiving vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.